SCHEMBL2364774

SCHEMBL2364774

O=C1C(c2ccccc2O)c2c(OCc3ccccc3)cccc2N1C(c1ccccc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 1/20 0.40
MAPT P10636 2/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM1A O60341 2/20 0.36
HTR1A P08908 2/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
MAOB P27338 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KDM4C Q9H3R0 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MCL1 Q07820 1/20 0.35
HTR6 P50406 1/20 0.35
TNKS2 Q9H2K2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2306100 0.78 MAOB (0.41) MAOBSLC6A2SLC6A3KDM4CMEN1
SCHEMBL12470014 0.76 MAOB (0.41) MAPTHTR1AMAOBKDM4CMEN1
SCHEMBL2303930 0.73 MAOB (0.41) MAPTMAPK1TDP1MAOBKMT2A
SCHEMBL15312918 0.71 MAOB (0.45) TDP1L3MBTL1ADRA1AMAOBKMT2A
SCHEMBL384667 0.68 EDNRB (0.34) MAPTMAPK1MEN1KMT2AALDH1A1
SCHEMBL6356278 0.64 MAPT (0.60) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL130119 0.63 APP (0.72) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL1121687 0.63 MAPT (0.55) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL5674481 0.63 MAPT (0.76) MAPTMAPK1TDP1L3MBTL1HTR1A
SCHEMBL11974258 0.62 MAPK1 (0.54) MAPTMAPK1TDP1L3MBTL1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350090-A2 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2011-08-03 EP disclosed